JP2020512348A5 - - Google Patents

Download PDF

Info

Publication number
JP2020512348A5
JP2020512348A5 JP2019553023A JP2019553023A JP2020512348A5 JP 2020512348 A5 JP2020512348 A5 JP 2020512348A5 JP 2019553023 A JP2019553023 A JP 2019553023A JP 2019553023 A JP2019553023 A JP 2019553023A JP 2020512348 A5 JP2020512348 A5 JP 2020512348A5
Authority
JP
Japan
Prior art keywords
biomolecule
radiolabeled
group
substituted
radiolabeled biomolecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2019553023A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020512348A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/052211 external-priority patent/WO2018178936A1/en
Publication of JP2020512348A publication Critical patent/JP2020512348A/ja
Publication of JP2020512348A5 publication Critical patent/JP2020512348A5/ja
Priority to JP2023062556A priority Critical patent/JP2023076712A/ja
Priority to JP2025027120A priority patent/JP2025071280A/ja
Withdrawn legal-status Critical Current

Links

JP2019553023A 2017-03-30 2018-03-29 放射標識生体分子およびその使用 Withdrawn JP2020512348A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023062556A JP2023076712A (ja) 2017-03-30 2023-04-07 放射標識生体分子およびその使用
JP2025027120A JP2025071280A (ja) 2017-03-30 2025-02-21 放射標識生体分子およびその使用

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201762478754P 2017-03-30 2017-03-30
US62/478,754 2017-03-30
US201762500692P 2017-05-03 2017-05-03
US62/500,692 2017-05-03
US201762529532P 2017-07-07 2017-07-07
US62/529,532 2017-07-07
US201762583134P 2017-11-08 2017-11-08
US62/583,134 2017-11-08
PCT/IB2018/052211 WO2018178936A1 (en) 2017-03-30 2018-03-29 Radiolabeled biomolecules and their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023062556A Division JP2023076712A (ja) 2017-03-30 2023-04-07 放射標識生体分子およびその使用

Publications (2)

Publication Number Publication Date
JP2020512348A JP2020512348A (ja) 2020-04-23
JP2020512348A5 true JP2020512348A5 (cg-RX-API-DMAC7.html) 2021-05-06

Family

ID=62017598

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019553023A Withdrawn JP2020512348A (ja) 2017-03-30 2018-03-29 放射標識生体分子およびその使用
JP2023062556A Withdrawn JP2023076712A (ja) 2017-03-30 2023-04-07 放射標識生体分子およびその使用
JP2025027120A Pending JP2025071280A (ja) 2017-03-30 2025-02-21 放射標識生体分子およびその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023062556A Withdrawn JP2023076712A (ja) 2017-03-30 2023-04-07 放射標識生体分子およびその使用
JP2025027120A Pending JP2025071280A (ja) 2017-03-30 2025-02-21 放射標識生体分子およびその使用

Country Status (5)

Country Link
US (2) US20200188541A1 (cg-RX-API-DMAC7.html)
EP (1) EP3600453A1 (cg-RX-API-DMAC7.html)
JP (3) JP2020512348A (cg-RX-API-DMAC7.html)
CN (1) CN110709106A (cg-RX-API-DMAC7.html)
WO (1) WO2018178936A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102899941B1 (ko) 2019-05-24 2025-12-16 듀크 유니버시티 18f-방사선 표지된 생체 분자
EP4058423A1 (en) 2019-11-13 2022-09-21 Duke University Radiohalogen prosthetic moieties and radiolabeled biomolecules
EP3967674A1 (en) * 2020-09-11 2022-03-16 Precirix N.V. Reactions of radioactive compounds facilitated by a solid phase
EP4337265A4 (en) * 2021-05-14 2026-03-25 Purdue Research Foundation TARGETED FOLATE RECEPTOR CONJUGATIONS WITH BRUSH-ON ENZYME-CLEVABLE BINDERS AND METHODS OF USE IN CANCER IMAGING AND TREATMENT
KR20240095178A (ko) * 2021-09-01 2024-06-25 듀크 유니버시티 단백질을 방사성 할로겐으로 부위-특이적 표지하기 위한 시약 및 이의 제조방법 및 사용 방법
AU2023276697A1 (en) 2022-05-23 2024-12-12 Cereius, Inc. Her2-binding agents and uses thereof
CN118388451A (zh) * 2024-06-28 2024-07-26 四川大学 一种放射性标记的成纤维细胞活化蛋白抑制剂及其制备方法和应用
WO2026128025A2 (en) 2024-07-03 2026-06-18 Solve Therapeutics, Inc. Anti-ror2 antibody-radionuclide conjugates

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US5302700A (en) 1988-05-23 1994-04-12 Duke University Radiohalogenation conjugate technology
FI903489A7 (fi) 1988-11-11 1990-07-10 Medical Res Council Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö
EP0859841B1 (en) 1995-08-18 2002-06-19 MorphoSys AG Protein/(poly)peptide libraries
GB9722131D0 (en) 1997-10-20 1997-12-17 Medical Res Council Method
US7696320B2 (en) 2004-08-24 2010-04-13 Domantis Limited Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor
NZ540194A (en) 2002-11-08 2008-07-31 Ablynx Nv Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
CA2634666C (en) * 2005-12-22 2015-05-26 Duke University Stabilized compositions and methods for radiolabeling pharmaceuticals with alpha-particle emitters
EP2247615B1 (en) 2008-02-14 2014-07-30 Bristol-Myers Squibb Company Targeted therapeutics based on engineered proteins that bind egfr
KR101389166B1 (ko) 2011-01-12 2014-04-24 미쯔비시 레이온 가부시끼가이샤 활성 에너지선 경화성 수지 조성물, 미세 요철 구조체 및 미세 요철 구조체의 제조 방법
KR101279584B1 (ko) 2011-06-24 2013-06-28 대한민국 (식품의약품안전처장) Erbb2 수용체에 선택적으로 결합하는 압타머 및 이의 용도
EP2991687A4 (en) * 2013-05-02 2016-11-09 Univ Duke PROSTHETIC COMPOUNDS FOR MARKING INTERNALIZING BIOMOLECULES
JP6289733B2 (ja) * 2014-07-29 2018-03-07 フレイエ ユニヴェルシテイト ブリュッセルVrije Universiteit Brussel 癌の予防及び/又は治療に用いるための放射標識抗体断片

Similar Documents

Publication Publication Date Title
JP6533222B2 (ja) 新規の抗体−薬剤コンジュゲート及び治療におけるその使用
JP7381478B2 (ja) 単一分子量ポリサルコシンを含むリガンド-薬物-複合体
IL295571A (en) Fibroblast activation protein ligands for targeted delivery applications
TWI850308B (zh) 包含配位子、間隔區、胜肽連接子及生物分子之複合體
JP6096371B2 (ja) ビオチン改変体、ストレプトアビジン変異体およびそれらの利用
US20160303247A1 (en) Antibody-Drug Conjugates and Related Compounds, Compositions, and Methods
AU2018317859A1 (en) 6-amino-7,9-dihydro-8h-purin-8-one derivatives as immunostimulant Toll-like receptor 7 (TLR7) agonists
EP3668871A1 (en) 6-amino-7,9-dihydro-8h-purin-8-one derivatives as immunostimulant toll-like receptor 7 (tlr7) agonists
EP3668868A1 (en) Toll-like receptor 7 (tlr7) agonists having a tricyclic moiety, conjugates thereof, and methods and uses therefor
JP2014516993A5 (cg-RX-API-DMAC7.html)
RU2015119557A (ru) Конъюгаты лекарственное вещество-белок
US11667724B2 (en) Anti-human CEACAM5 antibody Fab fragment
KR20130132935A (ko) Nota에 의해 복합체를 형성한 알루미늄―〔18〕플루오라이드로 표지된 her2 결합 펩티드
US12202908B2 (en) Complex having anti-human MUC1 antibody Fab fragment, peptide linker and/or ligand
US20250073359A1 (en) Radiolabeled biomolecules and their use
JP2019534706A5 (cg-RX-API-DMAC7.html)
KR20130132939A (ko) 18f - 함유 유기실리콘 화합물로 표지된 her2 결합 펩티드
JP2020524669A (ja) 抗globo h抗体を含有する抗体−薬物コンジュゲートおよびその使用
JP2025503493A5 (cg-RX-API-DMAC7.html)
EP3727465A2 (en) Transition metal-based functional moieties for preparing cell targeting conjugates
US7205385B2 (en) Polymerization method for the synthesis of polypeptide imaging agents
JP2022518598A5 (cg-RX-API-DMAC7.html)
RU2007118385A (ru) Контрастные агенты для направлений доставки во внеклеточный матрикс
JP2025161882A (ja) 放射性ハロゲン補欠部分および放射標識生体分子
NL2020120B1 (en) Methods for preparing cell targeting conjugates and conjugates obtainable by said methods